Table 6.
Results of the preference analyses conducted during the dry seasons of 2008–2014.
| Year | Trials | Sites | No. of entries | Ranking of most preferred varieties/lines |
Correlation between preferences |
|||||
|---|---|---|---|---|---|---|---|---|---|---|
| 1st | 2nd | 3rd | 4th | Male vs. Female | Farmers vs. Researchers | Farmers vs. yield | ||||
| 2008−09 | On-station | Site 1 | 12 | Gontra Bidhan-2 | Canning 7 | Lal Minikit | Satabdi | 0.81** | 0.85** | 0.86* |
| On-farm (2)a |
Site 1 | 12 | Gontra Bidhan-2 | Canning 7 | Satabdi | Lalat | 0.73** | 0.86** | 0.69* | |
| Site 2 | 12 | Gontra Bidhan-2 | Canning 7 | Satabdi | Khitish | 0.93** | 0.79** | 0.66* | ||
| 2009−10 | On-station | Site 1 | 8 | Gontra Bidhan-2 | Annada | Rasi | Boby | 0.81** | 0.85*** | 0.86* |
| On-farm (2) |
Site 1 | 8 | Gontra Bidhan-2 | Boby | Rasi | Canning 7 | 0.93** | 0.08 | 0.72** | |
| Site 2 | 8 | Canning 7 | Annada | Rasi | Boby | 0.97** | 0.86** | 0.16 | ||
| 2011−12 | On-station | Site 1 | 8 | Boby | Bidhan-2 | Lal Minikit | Annada | 0.91* | 0.82* | 0.89* |
| On-farm (3) |
Site 1 | 8 | Lal Minikit | Annada | Gontra Bidhan-2 | Boby | 0.83 | 0.51 | 0.66 | |
| Site 2 | 8 | Gontra Bidhan-2 | Boby | Annada | Lal Minikit | 0.83 | 0.64 | 0.70 | ||
| Site 3 | 8 | Gontra Bidhan-2 | Annada | Lal Minikit | Satabdi | 0.93* | 0.82 | 0.73 | ||
| 2012−13 | On-farm (3) |
Site 1 | 10 | Gontra Bidhan-2 | Boby | Annada | Parijat/Super Sankar | 0.46 | 0.39 | 0.80** |
| Site 2 | 10 | Super Sankar | Gontra Bidhan-2 | Boby | N Sankar | 0.78** | 0.52 | 0.84** | ||
| Site 3 | 10 | Boby | Gontra Bidhan-2 | Super Sankar | Annada | 0.94** | 0.90*** | 0.32 | ||
| 2013−14 | On-farm (3) |
Site 1 | 10 | Lal Minikit | Lalat | Satabdi | Boby | 0.83** | 0.95** | 0.65* |
| Site 2 | 10 | Lal Minikit | Lalat | Annada/IR 64 Saltol | – | 0.20 | 0.95** | 0.68* | ||
| Site 3 | 10 | Lal Minikit | Lalat/IR 64 Saltol | Boby | – | 0.83** | 0.92** | 0.65* | ||
*, ** significant at P< 0.05, and 0.01, respectively.
Numbers in parenthesis in the second column are on-farm trials.